Guru Ownership Trend
Guru Analysis for Zenas BioPharma, Inc. (ZBIO)
Zenas BioPharma, Inc. (ZBIO), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.49 M.
Top institutional holders include Cliff Asness and Steven Cohen.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $4.39 M net outflow during the quarter.
Recent activity highlights Steven Cohen who opened a new position. Conversely, Cliff Asness reduced exposure by 39.0%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Zenas BioPharma, Inc. (ZBIO)
Major holders include Cliff Asness ($789,319), Steven Cohen ($409,532). According to the latest reported data, 2 tracked investment managers collectively hold approximately 47,236 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $4.39 M, with 1 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited ZBIO. The total reported sell value was $4.8 M.
Yes, 1 managers opened new positions in ZBIO, and 0 increased their existing holdings. The total reported buy value was $409,532.